We are excited to host an exclusive Investors Lunch about longevity and rejuvenation at Hotel Seehof on May 25th.

An invite-only event, it brings together 50 institutional investors, interested in the longevity-related research and breakthrough technologies, and provides latest insights into the longevity field.

We are honored to present you the esteemed Jury of the Maximon Longevity Prize for Translational Research: Prof. Brian Kennedy, Dr. Ashish Rajput, Prof. Dr. Collin Ewald, Sebastien Thuault, Prof. Dr. Evelyne Bischof and Prof. Joao Pedro de Magalhaes.

Applications for the 50k CHF prize are open until July 31st, 2022.

We are happy to welcome an impressive line-up of speakers at the upcoming Longevity Investors Conference in Gstaad on September 28th-30th like:

Aubrey de Grey, George Church, Nir Barzilai, Eric Verdin, Alex Zhavoronkov and many more.

Early bird tickets are still available, click below for more details. 

We are proud to announce that our two ventures Avea Life and Biolytica were included in Sifted’s selection of early stage startups to watch in the field of longevity.

In their Longevity report, you'll find them next to other prevention startups like Rosita Longevity and Pharmamel.

Our Founding Partner Dr. Tobias Reichmuth will speak at the Longevity Leaders World Congress on April 26-27th, 2022 in London, United Kingdom.

He will hold a speech on "Building and investing in longevity companies", as well as participate in an investment panel.

In the past month we onboarded 5 new colleagues:

• Anna Giorgi 
• Giovanni Grosso 
• Cédric Diego Vollmar
• Shaniece Parker 
• Eva Vodopija

For more details click on the link below.